Sign Up to like & get
recommendations!
0
Published in 2021 at "Scientific reports"
DOI: 10.1038/s41598-021-84618-7
Abstract: Coagulation Factor XIa (FXIa) is an emerging target for antithrombotic agent development. The M358R variant of the serpin alpha-1 antitrypsin (AAT) inhibits both FXIa and other proteases. Our aim was to enhance the specificity of…
read more here.
Keywords:
m358r;
factor xia;
phage;
aat ... See more keywords